Banner

A comparative study to assess the efficacy of dexmedetomidine as an adjuvant to bupivacaine in the ultrasound-guided pectoral and serratus plane nerve block for patients undergoing modified radical mastectomy

• 2021
Back
Publication Information
Authors Enas W. Mahdya , Ahmed H.Abd Elrahmanb , Elsayed M. Abdelzaamb
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background and aims
Dexmedetomidine has been noticed to be safe and efficient in prolonging the
duration of peripheral nerve blocks. This study was designed to compare the length,
quality of postoperative analgesia, hemodynamic stability, and patient’s satisfaction
and number of patients requiring analgesia with the addition of dexmedetomidine to
bupivacaine versus plain bupivacaine in pectoral nerve block (pecs) for modified
radical mastectomy (MRM).
Patients and methods
These patients were randomly allocated using a computerized random number
generator into two groups: group I (control group) (30 patients) received 25 ml of
0.25% of plain bupivacaine that was used for modified pecs block. Group II (study
group) (30 patients) received 25 ml of 0.25% of plain bupivacaine plus
dexmedetomidine (Precedex) 1 μg/kg that were used for pecs block.
Results
The results showed a longer duration of analgesia in group II (21±3 h) in comparison
with group I (16±4 h). Statistical analysis showed a statistically highly significant
(P=0.006). Also, consumption of morphine was lower in group II (5±3 mg/24 h) in
comparison with group I (9±4 mg/24 h). Statistical analysis showed a statistically
significant (P=0.01).
Conclusion
Dexmedetomidine as an adjunct to bupivacaine helps increase the duration and
improves the quality of postoperative analgesia in pecs block without serious side
effects.